Norden Group LLC lifted its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 6.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,079 shares of the technology company’s stock after purchasing an additional 187 shares during the quarter. Norden Group LLC’s holdings in Novanta were worth $394,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in NOVT. Norges Bank acquired a new stake in shares of Novanta during the 4th quarter worth approximately $48,442,000. T. Rowe Price Investment Management Inc. grew its stake in Novanta by 69.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 680,169 shares of the technology company’s stock valued at $103,910,000 after acquiring an additional 279,793 shares during the period. Schroder Investment Management Group grew its stake in Novanta by 52.5% in the 4th quarter. Schroder Investment Management Group now owns 271,583 shares of the technology company’s stock valued at $41,359,000 after acquiring an additional 93,511 shares during the period. Millennium Management LLC grew its stake in Novanta by 2,714.7% in the 4th quarter. Millennium Management LLC now owns 88,297 shares of the technology company’s stock valued at $13,489,000 after acquiring an additional 85,160 shares during the period. Finally, Northern Trust Corp grew its stake in Novanta by 14.0% in the 4th quarter. Northern Trust Corp now owns 487,688 shares of the technology company’s stock valued at $74,504,000 after acquiring an additional 59,986 shares during the period. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Price Performance
Novanta stock opened at $123.24 on Thursday. The company’s fifty day moving average price is $126.04 and its 200 day moving average price is $130.68. Novanta Inc. has a 1 year low of $98.76 and a 1 year high of $186.75. The stock has a market capitalization of $4.43 billion, a P/E ratio of 62.88 and a beta of 1.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.70 and a current ratio of 2.56.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th.
View Our Latest Stock Report on Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
See Also
- Five stocks we like better than Novanta
- What Investors Need to Know to Beat the Market
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- How to Buy Cheap Stocks Step by Step
- How Marvell Went From Short Target to Breakout Star
- How to Read Stock Charts for Beginners
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.